These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30185772)

  • 1. Correction to: Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition.
    Zhang T; Li S; Li J; Yin F; Hua Y; Wang Z; Lin B; Wang H; Zou D; Zhou Z; Xu J; Yi C; Cai Z
    Cell Death Dis; 2018 Sep; 9(9):902. PubMed ID: 30185772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
    Ye TH; Yang FF; Zhu YX; Li YL; Lei Q; Song XJ; Xia Y; Xiong Y; Zhang LD; Wang NY; Zhao LF; Gou HF; Xie YM; Yang SY; Yu LT; Yang L; Wei YQ
    Cell Death Dis; 2019 Sep; 10(10):722. PubMed ID: 31558703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3.
    Zhang T; Li J; Yin F; Lin B; Wang Z; Xu J; Wang H; Zuo D; Wang G; Hua Y; Cai Z
    Oncogene; 2019 Jun; 38(23):4655-4656. PubMed ID: 30770898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.
    Lei FX; Jin L; Liu XY; Lai F; Yan XG; Farrelly M; Guo ST; Zhao XH; Zhang XD
    Cell Death Dis; 2019 Mar; 10(3):225. PubMed ID: 30837450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction Note to: Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition.
    Zhang T; Li S; Li J; Yin F; Hua Y; Wang Z; Lin B; Wang H; Zou D; Zhou Z; Xu J; Yi C; Cai Z
    Cell Death Dis; 2021 Mar; 12(3):281. PubMed ID: 33723213
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction to: FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.
    Lai H; Zhao X; Qin Y; Ding Y; Chen R; Li G; Labrie M; Ding Z; Zhou J; Hu J; Ma D; Fang Y; Gao Q
    J Exp Clin Cancer Res; 2019 Oct; 38(1):415. PubMed ID: 31615580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Calcium sensing receptor protects high glucose-induced energy metabolism disorder via blocking gp78-ubiquitin proteasome pathway.
    Wang Y; Gao P; Wei C; Li H; Zhang L; Zhao Y; Wu B; Tian Y; Zhang W; Wu L; Wang R; Xu C
    Cell Death Dis; 2020 Sep; 11(9):784. PubMed ID: 32958752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling.
    Usman MW; Gao J; Zheng T; Rui C; Li T; Bian X; Cheng H; Liu P; Luo F
    Cell Death Dis; 2019 Jun; 10(7):501. PubMed ID: 31235854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
    Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
    Oncogene; 2020 Mar; 39(10):2224-2226. PubMed ID: 31819168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.
    Moro L; Arbini AA; Marra E; Greco M
    Int J Oncol; 2016 Jun; 48(6):2722. PubMed ID: 27082245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.
    Vantaku V; Putluri V; Bader DA; Maity S; Ma J; Arnold JM; Rajapakshe K; Donepudi SR; von Rundstedt FC; Devarakonda V; Dubrulle J; Karanam B; McGuire SE; Stossi F; Jain AK; Coarfa C; Cao Q; Sikora AG; Villanueva H; Kavuri SM; Lotan Y; Sreekumar A; Putluri N
    Oncogene; 2020 Oct; 39(40):6387-6392. PubMed ID: 32820250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author Correction: Yolk sac macrophage progenitors traffic to the embryo during defined stages of development.
    Stremmel C; Schuchert R; Wagner F; Thaler R; Weinberger T; Pick R; Mass E; Ishikawa-Ankerhold HC; Margraf A; Hutter S; Vagnozzi R; Klapproth S; Frampton J; Yona S; Scheiermann C; Molkentin JD; Jeschke U; Moser M; Sperandio M; Massberg S; Geissmann F; Schulz C
    Nat Commun; 2018 Sep; 9(1):3699. PubMed ID: 30194428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: Bioprospection of actinobacteria derived from freshwater sediments for their potential to produce antimicrobial compounds.
    Zothanpuia ; Passari AK; Leo VV; Chandra P; Kumar B; Nayak C; Hashem A; Abd Allah EF; Alqarawi AA; Singh BP
    Microb Cell Fact; 2018 Jun; 17(1):86. PubMed ID: 29871626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: eEF-2 kinase is a critical regulator of Warbrug effect through controlling PP2A-A synthesis.
    Cheng Y; Ren X; Yuan Y; Shan Y; Li L; Chen X; Zhang L; Takahashi Y; Yang JW; Han B; Liao J; Li Y; Harvey H; Ryazanov A; Robertson GP; Wan G; Liu D; Chen AF; Tao Y; Yang JM
    Oncogene; 2018 Aug; 37(33):4633-4634. PubMed ID: 29973686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis.
    Wei X; Liu Y; Gong C; Ji T; Zhou X; Zhang T; Wan D; Xu S; Jin P; Yang X; Li X; Ma D; Yang Z; Gao Q
    Anticancer Agents Med Chem; 2019; 19(1):140-142. PubMed ID: 31204622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.
    Fujiwara J; Sowa Y; Horinaka M; Koyama M; Wakada M; Miki T; Sakai T
    Int J Oncol; 2016 Feb; 48(2):854. PubMed ID: 26648205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.
    Asian Pac J Cancer Prev; 2017 Nov; 18(10):2895-2895. PubMed ID: 29171745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects.
    Jiang T; Xu G; Wang Q; Yang L; Zheng L; Zhao J; Zhang X
    Cell Death Dis; 2019 Sep; 10(10):716. PubMed ID: 31558696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to: TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
    Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
    BMC Cancer; 2020 Jan; 20(1):43. PubMed ID: 31959146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting proapoptotic proteins and EZH2.
    Peng Y; Zhao JL; Peng ZY; Xu WF; Yu GL
    Cell Death Dis; 2020 Sep; 11(9):791. PubMed ID: 32968043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.